"A Quantum Leap In Resources": Millennium CEO Dunsire In A Conversation On The Firm's First Year As Part Of Takeda (Pt. 1 Of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Dunsire takes stock of Millennium's business development mandate as part of a global organization, its clinical pipeline and other operational changes since the firm became the Takeda Oncology company.